The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Worth looking into this guy and the company he worked for , impressive recruitment. I think it will take time and hard work to get PSE fully into the market, Reveune growth this year is going to come vastly from Cirt which is a company maker of many times the market cap on it own and approaching critcal mass..that is the key to growing the company and supporting additional products. Today news is another step pushing the company forwards
Its doing the rounds on a few brazilian websites
LSE removing part of the link -Just search
streia-campanha-sincera-sobre-cancer-de-prostata-quando-voce-vai-liberar-esse-c.
in google news , then translate
nice find - link doesnt work .. good to see the brazilian press on this
https://oglobo.globo.com/saude/noticia/2023/11/06/antonio-***undes-estreia-campanha-sincera-sobre-cancer-de-prostata-quando-voce-vai-liberar-esse-c.ghtml
I disagree , by time the announce profitabilty it will be much to late to buy in, anyone with a brain should be looking 12 month infront of that date - what the market need need is the confidence that the company will grow to become profitable at scale and not burn through investors money.- that is just a smidge too early at the moment , but BUPA , Medicare and the growth curve thus far are all nudging in the strongly right direction from proof of concept to seroius growth.. Market cap v potential 90% margin high volume is very low, even in this market - Many cash burners much further away from profit with less pointetial and many more mid tern obsticales to overcome at significant premiums to OBD.
Really don’t think the market has took in the significance of the BUPA deal for CiRT… It’s came on the back of 2 blockbuster an and all had a good news hangover IMO .. In one full swoop. CiRT is available to BUPA s 41% share of the UK heath insurance that’s over 2.3 million people + now covered for and offered a CiRT test should they sadly ever need it - BUPA are huge over 40million world wide .. It’s a big door to kick down.. and a real sign of where this is going .. if they can get BUPA they can get much more
Aklee
You only have to sell 400 CiRT for a $1 million in Revs at a 90% gross margin
I think perhaps Mr Odey called on of his mates at AL - offloaded OAMs OBD shares by buying them off OAM himself (at a discount) via a AL nominee account - privacy assured … it looked a very odd set up -
I hadn’t put the two together - didn’t realise this scandal was linked to us .. what an idiot .. now it’s obvious - only answers half the puzzle - who snapped up the rest ?
Details on the flaw in the current rules below..
The report also highlights how flaws in the register of owners of UK companies – known as the ‘PSC Register’ – could also be facilitating corruption. Currently, nominees and trustees owning shares are not required to tell Companies House who they are acting for. The government is opposing an amendment by Lord Vaux that would bring transparency to these arrangements.
I think its odd that this vehicle has been used .. possibly giving the overall purchaser anonymity
Sir Henry Angest (born 6 July 1940) is a Swiss-born London-based banker and political donor. He is the chairman and formerly chief executive officer of Arbuthnot Latham, a merchant bank in the City of London.
NU
This chap owns the 56.3% interest in AL Nominees and is considered the controlling party (from the accounts)
Sir Henry Angest
https://en.wikipedia.org/wiki/Henry_Angest#Career
NU - Yes its interesting - not your straight forward investment RNS, but been dormant for years - maybe just a convienient holding vehicle - Either way They (and thier senior partners) had confidence to aquire 10% which shows that its not only us few on LSE taking note of recent developements
Abuthnot Latham only significant shareholder
1 active person with significant control / 0 active statements
Abuthnot Latham & Co., Limited. Could be held for anyone
I dont think these would have been bought on the market .. All these invesment guys know each other, someone wanted to reduce and someone wanted a big stake there not been enough liqiduty, pretty sure we will get another very soon
Its been dormant since 1987
Hmmm - I reckon they have bought off a existing holder /
Something odd - The company is listed at dormant on companies house ?
https://find-and-update.company-information.service.gov.uk/company/01031723/filing-history
Morning Dug
Agree, I think OBD will be in discussions over PSE, may be a little premature at the moment.. The kicker I'm hopeful for is the first deal for Cirt with a hospital group in the US.. Would also be good to see some evidence of when CiRT will go live with BUPA
One thing I do like about the current management is their tendency to meet /beat deadlines.. Something that is completely unheard of in AIM BIO's .. to get the PSE ready is such a timeframe is a testament to their competence, the rapid Medicare code approval for both Cirt and PSE is no fluke .. its shows that they (or someone they employ) really know what they are doing ,answering all the questions before they are asked and paying attention to detail.